INTRODUCTION:Cardiovascular disease (CVD) counts for a major portion of morbidity and mortality globally mostly accompanied by lipid abnormalities. Being at increased risk of cardiac injury, critically ill patients suffer from various lipid disorders. Lipid homeostasis has been efficiently restored by the introduction of probiotics. The aim of this trial was to determine the effect of probiotics on inflammation, antioxidant capacity and lipid peroxidation in critically ill patients. METHODS:Forty patients admitted to the intensive care unit were randomized to receive placebo or probiotic for 7 days. Serum levels of triglyceride (TG), total cholesterol, HDL-C, LDL-C and high- sensitivity C-reactive protein (hs-CRP) were measured before initiation of the study and on the 7(th) day. RESULTS: There was a significant difference between two groups regarding the levels of TG, HDL and hs-CRP at the end of the study (P= 0.043, <0.001 and 0.003, respectively); however, there was not a significant difference in total cholesterol and LDL-C levels. CONCLUSION: Administration of probiotics in critically ill patients reduced the levels of TG and hs-CRP and increased HDL-C levels. However, no significant change was detected in levels of total cholesterol or LDL-C.
RCT Entities:
INTRODUCTION:Cardiovascular disease (CVD) counts for a major portion of morbidity and mortality globally mostly accompanied by lipid abnormalities. Being at increased risk of cardiac injury, critically illpatients suffer from various lipid disorders. Lipid homeostasis has been efficiently restored by the introduction of probiotics. The aim of this trial was to determine the effect of probiotics on inflammation, antioxidant capacity and lipid peroxidation in critically illpatients. METHODS: Forty patients admitted to the intensive care unit were randomized to receive placebo or probiotic for 7 days. Serum levels of triglyceride (TG), total cholesterol, HDL-C, LDL-C and high- sensitivity C-reactive protein (hs-CRP) were measured before initiation of the study and on the 7(th) day. RESULTS: There was a significant difference between two groups regarding the levels of TG, HDL and hs-CRP at the end of the study (P= 0.043, <0.001 and 0.003, respectively); however, there was not a significant difference in total cholesterol and LDL-C levels. CONCLUSION: Administration of probiotics in critically illpatients reduced the levels of TG and hs-CRP and increased HDL-C levels. However, no significant change was detected in levels of total cholesterol or LDL-C.
Authors: Z Guo; X M Liu; Q X Zhang; Z Shen; F W Tian; H Zhang; Z H Sun; H P Zhang; W Chen Journal: Nutr Metab Cardiovasc Dis Date: 2011-09-17 Impact factor: 4.222
Authors: W Koenig; M Sund; M Fröhlich; H G Fischer; H Löwel; A Döring; W L Hutchinson; M B Pepys Journal: Circulation Date: 1999-01-19 Impact factor: 29.690
Authors: Stefan Barlage; Carsten Gnewuch; Gerhard Liebisch; Zsuzsanna Wolf; Franz-Xaver Audebert; Thomas Glück; Dieter Fröhlich; Bernhard K Krämer; Gregor Rothe; Gerd Schmitz Journal: Intensive Care Med Date: 2009-08-08 Impact factor: 17.440
Authors: José V Lozano; Vicente Pallarés; Luis Cea-Calvo; José L Llisterri; Cristina Fernández-Pérez; Juan C Martí-Canales; Jose Aznar; Vicente Gil-Guillén; Josep Redón Journal: Curr Med Res Opin Date: 2008-01-23 Impact factor: 2.580
Authors: A Mahmoodpoor; K Eslami; M Mojtahedzadeh; A Najafi; A Ahmadi; A Dehnadi-Moghadam; A Mohammadirad; M Baeeri; M Abdollahi Journal: Daru Date: 2010 Impact factor: 3.117